REDISTRIBUTION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ACCORDANCE WITH CHANGES IN GOLD GLOBAL INITIATIVE CLASSICIFICATION
- Authors: Salakhova I.N1, Vafina A.R1, Vizel I.Y.1, Vizel A.A1, Ilyinsky V.I2, Shakirova G.R1,2, Kudryavtseva E.Z3
-
Affiliations:
- Kazan State Medical University
- Republican Clinical Hospital
- City Clinical Hospital №16
- Issue: No 8 (2018)
- Pages: 66-71
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295551
- DOI: https://doi.org/10.18565/pharmateca.2018.8.66-71
- ID: 295551
Cite item
Abstract
Full Text
About the authors
I. N Salakhova
Kazan State Medical University
A. R Vafina
Kazan State Medical University
I. Yu Vizel
Kazan State Medical University
A. A Vizel
Kazan State Medical UniversityMD, Prof., Head of Department of Phthisiopulmonology
V. I Ilyinsky
Republican Clinical Hospital
G. R Shakirova
Kazan State Medical University; Republican Clinical Hospital
E. Z Kudryavtseva
City Clinical Hospital №16
References
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (GOLD): 2018 report. 2018. 123 p. www.coldcopd.prg
- Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. Пульмонология. 2014;24(3):15-36.
- Обновленный проект клинических рекомендаций: Хроническая обструктивная болезнь легких. Доступно по ссылке http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ дата посещения 29.07.2018.
- Вафин А.Ю., Визель A.A., Шерпутовский В.Г., и др. Заболевания органов дыхания в Республике Татарстан: многолетний эпидемиологический анализ. Вестник современной клинической медицины. 2016;9(1):24-31.
- Визель A.A., Салахова И.Н., Визель И.Ю., и др. Больные хронической обструктивной болезнью легких: анализ реальной клинической практики. Consilium Medicum. 2018;03:35-9
- Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of self-reported measure of medical еadherence. Med. Care. 1986;24(1):67-73.
- Cabrera Lopez C., Casanova Macario C., Marin Trigo J.M., et al. Comparison of the 2017 and 2015 Global initiative for Chronic Obstructive Lung Disease Reports. impact on grouping and outcomes. Am. J. Respir. Crit. Care Med. 2018;197(4) 463-69. doi: 10.1164/rccm.201707-1363OC.
- Kaplan A., Thomas M. Screening for COPD: the gap between logic and evidence. Eur. Respir. Rev. 2017;26(143):pii: 160113. doi: 10.1183/16000617.0113-2016.
- Faner R., Noell G., Badia J.R., et al. Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLiPSE cohort. Respir. Med. 2018;141:14-9. Doi: 10.1016/ j.rmed.2018.06.015.
- Erol S., Sen E., Kilic Y.G., et al. Does the 2017 revision improve the ability of GOLD to predict risk of future moderate and severe exacerbation? Clin. Respir. J. 2018 Jun 5. doi: 10.1111/crj.12914. [Epub ahead of print].
- Hoogendoorn M., Feenstra T.L., Hoogenveen R.T., et al. Association between lung function and exacerbation frequency in patients with COPD. int. J. Chron. Obstruct. Pulmon. Dis. 2010;5:435-44. doi: 10.2147/COPD.S13826.
- Jones P.W., Beeh K.M., Chapman K.R., et al. Minimal clinically important differences in pharmacological trials. Am. J. Respir. Crit. Care Med. 2014;189(3):2505. doi: 10.1164/rccm.201310-1863PP
- Garcia Garcia S., Carazo Fernéndez L., Juan Garcia J., Naveiro Rilo J.C. Chronic obstructive pulmonary disease in real life. LEONPOC study. Aten. Primaria. 2017;49(10):603-10.